Potassium citrate 10 MEQ Extended Release Oral Tablet — RxCUI 199381
RxNorm drug concept · Semantic clinical drug
RxCUI 199381
Semantic clinical drug · SCD
● Current RxNorm concept 42 FDA products
72 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI199381
Official namePotassium citrate 10 MEQ Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asK+ citrate 10 MEQ Extended Release Oral Tablet; Pot citrate 10 MEQ Extended Release Oral Tablet; potassium citrate 1080 MG Extended Release Oral Tablet
FDA products mapped42
Package NDCs mapped72
Reported Medicaid activity (SDUD)79,544 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Potassium Citrate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Great question. Potassium citrate works in two main ways. First, it increases the amount of citrate in your urine — citrate acts like a natural stone-fighter by grabbing onto calci...
- What exactly is potassium citrate doing to stop my kidney stones?
- Yes, it really does matter. You should take your dose with meals or within 30 minutes after eating — or with a bedtime snack if you have a dose then. Taking it on an empty stomach...
- Do I have to take this with food? Does it really matter?
🕸️ Concept Web — How Potassium citrate 10 MEQ Extended Release Oral T... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Potassium citrate 10 MEQ Extended Release Oral Tablet
RxCUI 199381 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Potassium citrate
54993IN
-
Potassium citrate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Urocit-K
220697BN
-
Urocit-K
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Potassium citrate Extended Release Oral Tablet
373529SCDF -
Potassium citrate Oral Product
1165131SCDG -
Potassium citrate Pill
1165132SCDG -
Potassium citrate Extended Release Oral Tablet [Urocit-K]
542395SBDF -
Urocit-K Oral Product
1186763SBDG -
Urocit-K Pill
1186764SBDG -
Extended Release Oral Tablet
316945DF -
Oral Product
1151131DFG - +1 more in this family
-
Potassium citrate Extended Release Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Potassium citrate 10 MEQ
358572SCDC -
Potassium citrate 10 MEQ Extended Release Oral Tablet [Urocit-K]
603281SBD -
Potassium citrate 10 MEQ [Urocit-K]
569610SBDC
-
Potassium citrate 10 MEQ
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Potassium citrate 10 MEQ
SCDC · 358572 -
Potassium citrate Extended Release Oral Tablet
SCDF · 373529 -
Potassium citrate Oral Product
SCDG · 1165131 -
Potassium citrate Pill
SCDG · 1165132
Brand-Name Concepts
-
Potassium citrate 10 MEQ Extended Release Oral Tablet [Urocit-K]
SBD · 603281 -
Potassium citrate 10 MEQ [Urocit-K]
SBDC · 569610 -
Potassium citrate Extended Release Oral Tablet [Urocit-K]
SBDF · 542395 -
Urocit-K Oral Product
SBDG · 1186763 -
Urocit-K Pill
SBDG · 1186764 -
Urocit-K
BN · 220697
📦 FDA Products & Package NDCs
42 products · 72 package NDCs
72 package NDCs map to RxCUI 199381 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00178-0610-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0178-0610-01) | UROCIT-K | Mission Pharmacal Company | 2009-12-30 |
| 00178-0615-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0178-0615-01) | UROCIT-K | Mission Pharmacal Company | 2010-01-27 |
| 00245-0070-11 | 100 TABLET in 1 BOTTLE (0245-0070-11) | Potassium Citrate | Upsher-Smith Laboratories, LLC | 2006-09-01 |
| 00245-0071-11 | 100 TABLET in 1 BOTTLE (0245-0071-11) | Potassium Citrate | Upsher-Smith Laboratories, LLC | 2006-09-01 |
| 00591-2682-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-2682-01) | Potassium Citrate | Actavis Pharma, Inc. | 2018-05-30 |
| 00591-2729-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-2729-01) | Potassium Citrate | Actavis Pharma, Inc. | 2018-05-30 |
| 00591-2742-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0591-2742-01) | Potassium Citrate | Actavis Pharma, Inc. | 2018-05-30 |
| 16571-0864-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-864... | POTASSIUM CITRATE | Rising Pharma Holdings, Inc. | 2024-12-15 |
| 16571-0865-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16571-865... | POTASSIUM CITRATE | Rising Pharma Holdings, Inc. | 2024-12-15 |
| 31722-0129-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-129-01) | POTASSIUM CITRATE | Camber Pharmaceuticals, Inc | 2021-02-15 |
| 31722-0130-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-130-01) | POTASSIUM CITRATE | Camber Pharmaceuticals, Inc | 2021-02-15 |
| 31722-0132-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-132-01) | POTASSIUM CITRATE | Camber Pharmaceuticals, Inc | 2021-02-15 |
| 42543-0406-01 | 100 TABLET in 1 BOTTLE (42543-406-01) | POTASSIUM CITRATE EXTENDED RELEASE | Strides Pharma Inc. | 2017-11-01 |
| 42543-0407-01 | 100 TABLET in 1 BOTTLE (42543-407-01) | POTASSIUM CITRATE EXTENDED RELEASE | Strides Pharma Inc. | 2017-11-01 |
| 42543-0408-01 | 100 TABLET in 1 BOTTLE (42543-408-01) | POTASSIUM CITRATE EXTENDED RELEASE | Strides Pharma Inc. | 2017-11-01 |
| 44523-0410-01 | 100 TABLET in 1 BOTTLE (44523-410-01) | Potassium Citrate | Biocomp Pharma, Inc. | 2024-12-03 |
| 44523-0415-01 | 100 TABLET in 1 BOTTLE (44523-415-01) | Potassium Citrate | Biocomp Pharma, Inc. | 2013-12-23 |
| 51407-0449-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51407-449-01) | Potassium Citrate | Golden State Medical Supply, Inc. | 2021-08-23 |
| 51407-0450-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51407-450-01) | Potassium Citrate | Golden State Medical Supply, Inc. | 2021-08-23 |
| 51407-0451-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51407-451-01) | Potassium Citrate | Golden State Medical Supply, Inc. | 2021-08-23 |
| 62559-0291-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62559-291-01) | Potassium Citrate | ANI Pharmaceuticals, Inc. | 2020-03-16 |
| 62559-0292-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62559-292-01) | Potassium Citrate | ANI Pharmaceuticals, Inc. | 2020-03-16 |
| 63629-1966-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-1966-1) | Potassium Citrate | Bryant Ranch Prepack | 2022-02-08 |
| 63629-8759-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (63629-8759-1) | Potassium Citrate | Bryant Ranch Prepack | 2022-08-25 |
| 65841-0536-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-536-01) | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 65841-0536-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-536-05) | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 65841-0536-06 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-536-06) | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 65841-0536-10 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-536-10) | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 65841-0536-16 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-536-16) | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 65841-0536-30 | 10 BLISTER PACK in 1 CARTON (65841-536-30) / 10 TABLET, EXT... | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 65841-0537-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-537-01) | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 65841-0537-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-537-05) | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 65841-0537-06 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-537-06) | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 65841-0537-10 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-537-10) | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 65841-0537-16 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-537-16) | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 65841-0537-30 | 10 BLISTER PACK in 1 CARTON (65841-537-30) / 10 TABLET, EXT... | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 65841-0538-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-538-01) | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 65841-0538-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-538-05) | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 65841-0538-06 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-538-06) | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 65841-0538-10 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-538-10) | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 65841-0538-16 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (65841-538-16) | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 65841-0538-30 | 10 BLISTER PACK in 1 CARTON (65841-538-30) / 10 TABLET, EXT... | Potassium Citrate | Zydus Lifesciences Limited | 2014-08-12 |
| 68084-0850-32 | 20 BLISTER PACK in 1 BOX, UNIT-DOSE (68084-850-32) / 1 TABL... | Potassium Citrate | American Health Packaging | 2014-11-12 |
| 68382-0536-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-536-01) | Potassium Citrate | Zydus Pharmaceuticals (USA) Inc. | 2014-08-12 |
| 68382-0536-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-536-05) | Potassium Citrate | Zydus Pharmaceuticals (USA) Inc. | 2014-08-12 |
| 68382-0536-06 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-536-06) | Potassium Citrate | Zydus Pharmaceuticals (USA) Inc. | 2014-08-12 |
| 68382-0536-10 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-536-10) | Potassium Citrate | Zydus Pharmaceuticals (USA) Inc. | 2014-08-12 |
| 68382-0536-16 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-536-16) | Potassium Citrate | Zydus Pharmaceuticals (USA) Inc. | 2014-08-12 |
| 68382-0536-30 | 10 BLISTER PACK in 1 CARTON (68382-536-30) / 10 TABLET, EXT... | Potassium Citrate | Zydus Pharmaceuticals (USA) Inc. | 2014-08-12 |
| 68382-0537-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-537-01) | Potassium Citrate | Zydus Pharmaceuticals (USA) Inc. | 2014-08-12 |
Observed labelers:
Zydus Lifesciences Limited (18) ·
Zydus Pharmaceuticals (USA) Inc. (18) ·
Bryant Ranch Prepack (8) ·
Actavis Pharma, Inc. (3) ·
Camber Pharmaceuticals, Inc (3) ·
Golden State Medical Supply, Inc. (3)
· +9 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.